Engineering Health Through Innovation

The Next Strategic Industry

In 2025, Taiwan crossed an important demographic threshold. More than one in five citizens is now over the age of 65, officially making the island a super-aged society. The transition has occurred at one of the fastest rates among advanced economies, creating mounting pressure on healthcare systems, labor markets, and long-term care services. At the same time, healthcare providers around the world are grappling with rising costs, staff shortages, and growing demand for medical care.

For Taiwan, these challenges are becoming catalysts for innovation. The same ecosystem that transformed the island into a global semiconductor powerhouse is increasingly being mobilized to address the future of healthcare. Artificial intelligence, advanced manufacturing, biotechnology, digital health, and medical research are converging to create new opportunities for both economic growth and healthcare delivery. Rather than treating healthcare solely as a public service, Taiwan is increasingly viewing it as a strategic industry with global potential.

Taiwan enters this transition with several advantages. Its National Health Insurance system provides coverage to virtually the entire population, creating one of the world’s most comprehensive healthcare networks and generating a rich environment for clinical research, population health studies, and healthcare innovation. Combined with strong universities, internationally recognized hospitals, and deep expertise in engineering and computing, these assets are creating fertile ground for the next generation of healthcare technologies.

Across the sector, organizations are pursuing a common objective: finding ways to deliver higher-quality healthcare more efficiently. Artificial intelligence is being deployed to support clinical decision-making, automate administrative tasks, accelerate research, and identify health risks before they become costly medical problems.

“Doctors are not looking for AI that replaces them. They are looking for AI that helps them,” said John Chuang, President of Onyx Healthcare. “The shortage of healthcare professionals is real, and technology can help us serve more patients with the resources we have.”

That perspective is increasingly shared across Taiwan’s healthcare ecosystem. From university hospitals and medical schools to digital health platforms and biotechnology companies, organizations are working to build a model centered on prevention, efficiency, and data-driven care. What is emerging is not simply a collection of innovative companies, but a coordinated effort to position Taiwan at the forefront of one of the world’s fastest-growing industries.

The question is no longer whether healthcare will become a major economic driver. The question is whether Taiwan can do for healthcare what it once did for semiconductors.

Where Medicine Meets Engineering

If artificial intelligence is transforming healthcare, data is becoming its most valuable raw material. Taiwan possesses an advantage that few countries can match. Through its National Health Insurance system, which provides coverage to 99.9 percent of the population, the island has built one of the world’s most comprehensive healthcare networks. Beyond improving access to care, the system has created a vast ecosystem of clinical knowledge, research opportunities, and healthcare data that is increasingly supporting innovation across medicine and life sciences.

Yet data alone is not enough. The challenge lies in turning information into better outcomes for patients, and that requires a new generation of healthcare professionals capable of navigating both medicine and technology.

One of Taiwan’s most significant advantages lies in the scale and continuity of its healthcare data. The National Health Insurance system, launched in 1995, covers virtually the entire population and connects providers across primary care clinics, regional hospitals, and major medical centers. Over three decades, the system has generated one of the world’s richest repositories of longitudinal health information, creating opportunities for clinical research, disease prevention, population health studies, and the development of artificial intelligence applications. While strict privacy protections remain essential, the breadth of available data gives researchers and healthcare innovators a unique environment in which to validate new technologies and better understand how diseases develop across large populations.

This is where Taiwan’s universities are playing a pivotal role. At National Yang Ming Chiao Tung University, medical education is being reimagined around what the institution describes as “Future Medicine”—an interdisciplinary approach that combines clinical medicine, engineering, computer science, biotechnology, and data science. The goal is not simply to train physicians who can use technology, but to cultivate innovators capable of developing it.

That interdisciplinary approach is increasingly extending beyond academia into Taiwan’s biotechnology sector. “Our approach balances innovation with pragmatism. By adapting existing compounds for new diseases, we reduce early-stage uncertainty while preserving the potential for breakthrough therapies in areas of high unmet medical need,” said Lawrence Wu, Chairman of BoYen Therapeutics.

Similar initiatives are emerging across Taiwan’s academic healthcare sector. Taipei Medical University has invested heavily in integrating artificial intelligence across its hospitals, research centers, and educational programs through a unified digital platform, while Kaohsiung Medical University is expanding international partnerships and English-language programs to prepare healthcare professionals for an increasingly global industry.

The result is a model that differs from many traditional healthcare systems. Rather than treating medicine, engineering, and research as separate disciplines, Taiwan is increasingly bringing them together within a single ecosystem. That convergence is creating a talent pipeline capable of supporting the next generation of medical AI, precision medicine, digital health, and biotechnology.

In many ways, Taiwan is attempting to do for healthcare talent what it once did for semiconductors: build a workforce designed for the industries of the future.

The Smart Healthcare Laboratory

Around the world, healthcare systems face a difficult equation: demand for medical services is rising faster than the supply of healthcare professionals. Aging populations, increasing chronic disease, and growing patient expectations are placing unprecedented pressure on hospitals and caregivers. The challenge is particularly acute in advanced economies, where labor shortages have become one of the sector’s most persistent concerns.

Taiwan is confronting the same realities. Rather than relying solely on workforce expansion, many healthcare institutions are turning to technology to improve efficiency, streamline operations, and enhance patient care.

This approach is transforming hospitals into testing grounds for healthcare innovation.

At National Yang Ming Chiao Tung University Hospital in Yilan, digital transformation is increasingly integrated into daily operations. Artificial intelligence, data platforms, and new hospital information systems are being deployed to improve workflows and support clinical decision-making. The hospital’s close connection to both the local community and the university system has also made it an important center for public health research and real-world healthcare innovation.

“It became very important to handle critical illness and major trauma because time is everything in an emergency,” said Dr. William Ji-Sien Huang, Superintendent of National Yang Ming Chiao Tung University Hospital.

The institution’s role extends beyond patient care. Long-term population studies conducted in Yilan have generated valuable insights into public health trends, helping bridge the gap between academic research and practical healthcare delivery. The region’s relatively stable population and comprehensive healthcare coverage have created an environment where innovations can be tested and refined before wider deployment.

Similar transformations are taking place elsewhere. Taipei Medical University has invested heavily in integrating clinical records, research data, and hospital operations through a unified digital infrastructure designed to improve efficiency across its healthcare network. Artificial intelligence is increasingly being used not only for diagnostics, but also for administrative tasks, workflow optimization, and resource management.

“We integrated all hospital systems into one platform,” said Chen Ray-Jade, Chairman of Taipei Medical University. “Now we can understand in real time how resources are being used and how the entire system is performing.”

The result is a shift in how hospitals operate. Rather than serving solely as treatment centers, Taiwan’s leading medical institutions are becoming living laboratories where healthcare technologies can be validated, refined, and deployed at scale. As AI continues to mature, that ability to combine research, clinical practice, and real-world implementation may prove to be one of Taiwan’s most significant competitive advantages.

Data, AI, and Prevention

For much of modern medical history, healthcare systems have been designed to treat disease after it appears. Today, that model is becoming increasingly difficult to sustain.

As populations age and chronic illnesses become more prevalent, healthcare costs are rising across the world. The challenge is particularly acute in Asia, where several countries are aging at unprecedented speeds while facing growing pressure on healthcare budgets and workforce capacity. Increasingly, policymakers, providers, and technology companies are reaching the same conclusion: preventing disease is far more effective—and far less expensive—than treating it.

This shift is creating new opportunities for artificial intelligence and health data.

Taiwan’s healthcare ecosystem is particularly well positioned to benefit from this transition. Its extensive healthcare infrastructure, high levels of digital adoption, and large volumes of clinical data provide fertile ground for predictive healthcare models designed to identify risks before they become medical crises.

For H2U, one of Taiwan’s leading digital health companies, prevention has become the foundation of its long-term strategy. Originally established as a workplace wellness platform, the company has expanded into health data management, personalized health services, and AI-driven healthcare solutions aimed at helping individuals make better decisions about their health.

“AI’s greatest value is helping people make health decisions,” said Saxon Chen, Co-Founder and CEO of H2U. “If we can identify risks earlier and intervene sooner, we can improve outcomes while reducing pressure on healthcare systems.”

The same philosophy is increasingly influencing medical technology. Rather than focusing exclusively on diagnosis and treatment, AI-powered tools are being developed to improve efficiency, identify patterns, and support earlier intervention. From medical imaging and remote patient monitoring to clinical workflow optimization, many of these technologies are designed to help healthcare professionals manage growing demand with limited resources.

“Healthcare workforce shortages are not going away,” said John Chuang, President of Onyx Healthcare. “AI can help clinicians focus their time where it matters most.”

The implications extend beyond hospitals. Preventive healthcare is creating opportunities across insurance, corporate wellness, digital health, and consumer healthcare markets. It is also reshaping how healthcare innovation is measured. Success is increasingly defined not only by the ability to treat disease, but by the ability to prevent it.

For Taiwan, that shift aligns naturally with a broader national strength: using technology to solve complex challenges at scale. As healthcare evolves from reactive treatment toward predictive and preventive care, the island is positioning itself at the center of one of the industry’s most significant transformations.

From Wellness to Molecular Innovation

The future of healthcare is being shaped not only in hospitals and research centers, but increasingly across the broader life sciences sector, where advances in biotechnology, nutrition, biomaterials, and preventive health are creating new opportunities for innovation.

This reflects a fundamental shift in how health is understood. As populations age and healthcare systems come under growing pressure, attention is moving beyond the treatment of disease toward the preservation of health. Longevity, wellness, prevention, and quality of life are becoming major areas of investment, creating demand for products and technologies that help people remain healthier for longer.

Taiwanese companies are increasingly positioning themselves at the center of this transformation.

TCI has emerged as one of the island’s leading health and wellness innovators, building a global business around nutraceuticals, beauty supplements, and preventive health products. Leveraging artificial intelligence to accelerate product development and manufacturing, the company reflects a broader trend toward data-driven innovation across the life sciences sector.

“We believe health management will become one of the most important industries of the future,” said Vincent Lin, Chairman of TCI Co., Ltd. “People are living longer, and they want to remain healthy throughout their lives.”

Yet some of Taiwan’s most ambitious innovations extend beyond consumer health.

At Amelio Biomedical, the focus is on molecular engineering. The company’s proprietary MACS (Metal Amino Click Synthesis) platform is being developed as a molecular manufacturing technology with potential applications across healthcare, agriculture, and sustainable industry. Current research includes advanced hemostatic agents designed to control severe bleeding, antimicrobial technologies, crop nutrition solutions, and treatments aimed at combating devastating agricultural diseases such as citrus greening.

Rather than targeting a single market, the technology is designed as a platform capable of generating solutions across multiple industries. The approach reflects a growing trend among Taiwanese innovators to combine expertise in chemistry, biology, engineering, and manufacturing to address large-scale global challenges.

“Molecular-level innovation can scale into national strategic industries when it is built on a foundation of science, manufacturability, and impact,” said Grace Li, Founder and CEO of Amelio Biomedical.

The significance of these developments extends beyond individual companies. Increasingly, Taiwan’s life sciences sector is drawing on capabilities originally developed in advanced manufacturing and technology, creating a new generation of businesses built around intellectual property, research, and scientific innovation. In many ways, Taiwan is applying the same formula that made it a global technology leader to the next frontier of healthcare and biotechnology.

Taiwan’s Healthcare Advantage

Few countries possess all the ingredients required to build a globally competitive healthcare innovation ecosystem.

Some have world-class hospitals. Others have strong universities, advanced manufacturing capabilities, or thriving technology sectors. Taiwan is unusual because it combines all of these strengths within a relatively compact and highly connected environment.

The same ecosystem that enabled the rise of the semiconductor industry is increasingly supporting the development of healthcare technologies, biotechnology, medical devices, and digital health solutions. Researchers work closely with clinicians, hospitals collaborate with technology companies, and universities are training professionals capable of operating across disciplines. This level of integration allows ideas to move more rapidly from research and development into real-world applications.

International partnerships are playing an increasingly important role in that process. Universities are expanding collaborations with leading institutions in the United States and Europe, hospitals are participating in global research initiatives, and private companies are seeking opportunities to commercialize technologies across international markets. At a time when healthcare challenges are becoming more global in nature, Taiwan is positioning itself as both a source of innovation and a partner in solving them.

The opportunity extends beyond healthcare itself. Advances in artificial intelligence, precision medicine, molecular engineering, and preventive health are creating entirely new markets that blur the boundaries between technology, life sciences, and advanced manufacturing. Many of the organizations featured in this report are operating at exactly those intersections.

“We want doctors not only to use technology,” said Dr. Shuu-Jiun Wang, Dean of the College of Medicine at National Yang Ming Chiao Tung University. “We want them to invent technology.”

That ambition increasingly reflects Taiwan’s broader vision. Having built one of the world’s most important technology ecosystems, the island is now applying those capabilities to one of humanity’s most important challenges: improving health. As healthcare enters a new era defined by data, artificial intelligence, and interdisciplinary innovation, Taiwan is positioning itself not merely to participate in that transformation, but to help lead it.